来宝网Logo

热门词:生物显微镜 水质分析仪 微波消解 荧光定量PCR 电化学工作站 生物安全柜

AED
现在位置首页>实验室原料试剂耗材>细胞生物学检测>信号传导检测>LC 品牌信号转导、肿瘤、临床前研究试剂现货优势、折扣促销,全系列产品7折扣促销,
LC 品牌信号转导、肿瘤、临床前研究试剂现货优势、折扣促销,全系列产品7折扣促销,
LC 品牌信号转导、肿瘤、临床前研究试剂现货优势、折扣促销,全系列产品7折扣促销,
  • LC 品牌信号转导、肿瘤、临床前研究试剂现货优势、折扣促销,全系列产品7折扣促销,

LC 品牌信号转导、肿瘤、临床前研究试剂现货优势、折扣促销,全系列产品7折扣促销,

产品报价:询价

更新时间:2023/4/3 18:11:18

地:美国

牌:LC ,LC LAB

号:LC

厂商性质: 生产型,

公司名称: 世联博研(北京)科技有限公司

产品关键词:

1120
访问人数
0
累计评论


王荣 : (18618101725) (18618101725)

(联系我时,请说明是在来宝网上看到的,谢谢!)


 

世联博研北京科技有限公司代理销售的LC 品牌信号转导、肿瘤、临床前研究试剂全系列产品大折扣优惠促销,详情致电免费电话:400-650-8506

 

Product #

Name

 

9CI — see Ridaforolimus, Cat. No. R-7040.

A-1803

A-769662, >99%

A-6880

17-AAG, >99%

 

AB-1010 — see Masitinib, Free Base, Cat. No. M-7007.

 

ABT-578 — see Zotarolimus, Cat. No. Z-9040.

 

AC010220 — see Quizartinib, Free Base, Cat. No. Q-4747 .

 

AC220 — see Quizartinib, Free Base, Cat. No. Q-4747 .

A-6900

6"-O-Acetyldaidzin, >98%

 

Acetyldinaline — see CI-994, Free Base, Cat. No. C-2606.

A-3000

6"-O-Acetylgenistin, >98%

A-7860

6"-O-Acetylglycitin, >98%

 

Adeo — see (R,S)-Rolipram, Cat. No. R-2020.

 

Adriacin — see its active ingredient, namely Doxorubicin, Free Base, Cat. No. D-4099 and Doxorubicin, Hydrochloride Salt, Cat. No. D-4000.

 

Adriamycin — see its active ingredient, namely Doxorubicin, Free Base, Cat. No. D-4099 and Doxorubicin, Hydrochloride Salt, Cat. No. D-4000.

 

Adriblastin — see its active ingredient, namely Doxorubicin, Free Base, Cat. No. D-4099 and Doxorubicin, Hydrochloride Salt, Cat. No. D-4000.

 

Adriblastina — see its active ingredient, namely Doxorubicin, Free Base, Cat. No. D-4099 and Doxorubicin, Hydrochloride Salt, Cat. No. D-4000.

A-8644

Afatinib, Free Base, >99%

 

Afinitor — see its active ingredient, namely Everolimus, Cat. No. E-4040.

 

AG 490 — see Tyrphostin AG 490, Cat. No. T-9142.

 

AG 1478 — see Tyrphostin AG 1478, Cat. No. T-7310.

 

AG-013736 — see Axitinib, Free Base, Cat. No. A-1107.

 

Alimta — see its active ingredient, namely Pemetrexed, Disodium Salt, Heptahydrate, Cat. No. P-7177.

 

17-(Allylamino)-17-Demethoxygeldanamycin — see 17-AAG, Cat. No. A-6880.

 

17-(Allylamino)geldanamycin — see 17-AAG, Cat. No. A-6880.

 

Alvespimycin — see 17-DMAG, Cat. No. D-3440.

 

AMG-706 — see Motesanib, Diphosphate Salt, Cat. No. M-2999 and Motesanib, Free Base, Cat. No. M-2900.

 

2'-Amino-3'-methoxyflavone — see PD 98059, Cat. No. P-4313.

 

AMN-107 — see Nilotinib, Cat. No. N-8207.

 

3-Angeloyl Ingenol — see Ingenol 3-Angelate, Cat. No. I-5900.

 

3-Angelyl Ingenol — see Ingenol 3-Angelate, Cat. No. I-5900.

 

Anthra(1,9-cd)pyrazol-6(2H)-one — see SP600125, Cat. No. S-7979.

 

Anthrapyrazolone — see SP600125, Cat. No. S-7979.

 

Antibiotic AM-2282 — see Staurosporine, Cat. No. S-9300.

 

Antibioitic S 7481F1 — see Cyclosporin A, Cat. No. C-6000.

 

ANX-530 — see Vinorelbine, Ditartrate Salt, Cat. No. V-8766 and Vinorelbine, Free Base, Cat. No. V-8799.

 

AP 23573 — see Ridaforolimus, Cat. No. R-7040.

 

Armala — see Pazopanib, Free Base, Cat. No. P-6706.

 

ARRY-142886 — see Selumetinib, Free Base, Cat. No. S-4490.

 

ARRY-886 — see Selumetinib, Free Base, Cat. No. S-4490.

A-1040

Ascomycin, >99%

 

Ascotoxin — see Brefeldin A, Cat. No. B-8500.

 

AT-877 — see Fasudil, Monohydrochloride Salt, Cat. No. F-4660 and HA-1077, Dihydrochloride Salt, Cat. No. H-2330.

 

ATS 1287B — see Leptomycin B, Free Acid, Cat. No. L-6100.

 

AUY922 — see NVP-AUY922, Free Base, Cat. No. N-5300.

 

AV-951 — see Tivozanib, Free Base, Cat. No. T-6466.

A-1107

Axitinib, Free Base, >99%

 

AY-22989 — see Rapamycin, Cat. No. R-5000.

 

AZD-0530 — see Saracatinib, Free Base, Cat. No. S-8906.

 

AZD2171 — see Cediranib, Free Base, Cat. No. C-4300 .

 

AZD-2281 — see Olaparib, Cat. No. O-9201.

 

AZD6244 — see Selumetinib, Free Base, Cat. No. S-4490.

 

B705008K112 — see Bryostatin 1, Cat. No. B-6697.

 

Baccatin III N-benzyl-β-phenylisoserine ester — see Paclitaxel, Cat. No. P-9600.

B-1080

BafilomycinA1, >95%

 

Bay 43-9006 — see Sorafenib, p-Toluenesulfonate Salt, Cat. No. S-8502 and Sorafenib, Free Base, Cat. No. S-8599.

 

N-Benzoyl-7-oxostaurosporine — see Stauprimide, Cat. No. S-9344.

 

4'-N-Benzoyl Staurosporine — see PKC412, Cat. No. P-7600.

B-2422

Bexarotene, Free Acid, >99%

 

BEZ235 — see NVP-BEZ235, Free Base, Cat. No. N-4288.

 

BFA — see Brefeldin A, Cat. No. B-8500.

 

BIBF1120 — see Intedanib, Free Base, Cat. No. I-9077.

 

BIBW-2992 — see BIIB021, Free Base, Cat. No. B-7100.

B-7100

BIIB021, Free Base, >99%

 

Biovelbin — see its active ingredient, namely Vinorelbine, Ditartrate Salt, Cat. No. V-8766 and Vinorelbine, Free Base, Cat. No. V-8799.

 

BIRB 796 — see Doramapimod, Free Base, Cat. No. D-2744.

 

BMS-354825 — see Dasatinib, Free Base, Cat. No. D-3307.

 

BMY-40481 — see Etoposide, Cat. No. E-4488 and Etoposide 4'-Phosphate, Free Acid, Cat. No. E-4444.

B-1408

Bortezomib, Free Base, >99%

B-1709

Bosutinib, Free Base, >99%

B-8500

Brefeldin A, >99%

B-6697

Bryostatin 1, >99%

B-3517

Bryostatin 2, >99%

 

BSI-201 — see Iniparib, Cat. No. I-5432.

 

Caelyx — see its active ingredient, namely Doxorubicin, Free Base, Cat. No. D-4099 and Doxorubicin, Hydrochloride Salt, Cat. No. D-4000.

C-3987

Calyculin A, >98%

 

Campto — see its active ingredient, namely Irinotecan, Hydrochloride Salt, Trihydrate, Cat. No. I-4122.

 

Camptosar — see its active ingredient, namely Irinotecan, Hydrochloride Salt, Trihydrate, Cat. No. I-4122.

 

Camptothecin 11 — see Irinotecan, Hydrochloride Salt, Trihydrate, Cat. No. I-4122.

C-1201

Canertinib, Dihydrochloride Salt, >99%

 

Capecitabin — see Capecitabine, Cat. No. C-2799.

C-2799

Capecitabine, >99%

 

Capecitibine — see Capecitabine, Cat. No. C-2799.

 

Capecytabine — see Capecitabine, Cat. No. C-2799.

 

Capiibine — see Capecitabine, Cat. No. C-2799.

 

Caprelsa — see Vandetanib, Cat. No. V-9402.

 

Captabin — see Capecitabine, Cat. No. C-2799.

 

Caxeta — see Capecitabine, Cat. No. C-2799.

 

CCI-779 — see Temsirolimus, Cat. No. T-8040.

C-4300

Cediranib, Free Base, >99%

 

Celebra — see its active ingredient, namely Celecoxib, Cat. No. C-1502.

 

Celebrex — see its active ingredient, namely Celecoxib, Cat. No. C-1502.

 

Celecox — see Celecoxib, Cat. No. C-1502.

C-1502

Celecoxib, >99%

 

CEP-701 — see Lestaurtinib, Cat. No. L-6307.

 

Certican — see its active ingredient, namely Everolimus, Cat. No. E-4040.

 

cFMS Receptor Tyrosine Kinase Inhibitor — see GW2580, Free Base, Cat. No. G-5903.

 

CGP41251 — see PKC412, Cat. No. P-7600.

 

CGP-57148B — see Imatinib, Free Base, Cat. No. I-5577 and Imatinib, Methanesulfonate Salt, Cat. No. I-5508.

 

CGP-79787 — see Vatalanib, Free Base, Cat. No. V-8355 and Vatalanib, Dihydrochloride Salt, Cat. No. V-8303.

C-3030

Chelerythrine Chloride, >99%

 

CHIR-258 — see Dovitinib, Free Base, Cat. No. D-3608 and Dovitinib, Lactate Salt, Cat. No. D-3699.

 

CHIR 911 — see CHIR99021, Free Base, Cat. No. C-6556.

C-6556

CHIR99021, Free Base, >99%

 

CI-940 — see Leptomycin B, Free Acid, Cat. No. L-6100.

C-2606

CI-994, Free Base, >99%

 

CI-1033 — see Canertinib, Dihydrochloride Salt, Cat. No. C-1201.

 

CI-1040 — see PD 184352, Free Base, Cat. No. P-8499.

 

Ciclosporin A — see Cyclosporin A, Cat. No. C-6000.

 

CL-1957A — see Leptomycin B, Free Acid, Cat. No. L-6100.

 

CNF-101 — see 17-AAG, Cat. No. A-6880.

 

CNF2024 — see BIIB021, Free Base, Cat. No. B-7100.

 

Cocarcinogen A1 — see Phorbol 12-Myristate 13-Acetate, Cat. No. P-1680.

 

Colforsin — see Forskolin, Cat. No. F-9929.

 

CP 127374 — see 17-AAG, Cat. No. A-6880.

 

CP-358774 — see Erlotinib, Free Base, Cat. No. E-4997 and Erlotinib, Hydrochloride Salt, Cat. No. E-4007.

 

CP-690550 — see Tofacitinib, Free Base, Cat. No. T-1377.

 

CPT-11 — see Irinotecan, Hydrochloride Salt, Trihydrate, Cat. No. I-4122.

C-7900

Crizotinib, Free Base, >99%

 

CsA — see Cyclosporin A, Cat. No. C-6000.

 

CSF-1 Receptor Inhibitor — see GW2580, Free Base, Cat. No. G-5903.

 

CT53518 — see Tandutinib, Free Base, Cat. No. T-7802.

 

CT99021 — see CHIR99021, Free Base, Cat. No. C-6556.

C-8460

CUDC-101, Free Base, >99%

 

Cyanein — see Brefeldin A, Cat. No. B-8500.

 

CYC202 — see Roscovitine, Cat. No. R-1234.

C-8700

Cyclopamine, Free Base, 99%

C-6000

Cyclosporin A, >99%

 

Cyclosporine — see Cyclosporin A, Cat. No. C-6000.

 

D04014 — see Enzastaurin, Free Base, Cat. No. E-4506.

 

Dacplat — see Oxaliplatin, Cat. No. O-7111.

D-2946

Daidzein, >99%

D-7878

Daidzin, >99%

D-3307

Dasatinib, Free Base, >99%

 

Decumbin — see Brefeldin A, Cat. No. B-8500.

 

Deforolimus — see Ridaforolimus, Cat. No. R-7040.

 

11-Deoxyjervine — see Cyclopamine, Free Base, Cat. No. C-8700.

 

12-Deoxyphorbol 13-Acetate — see Prostratin, Cat. No. P-4462.

 

dFdC — see Gemcitabine, Free Base, Cat. No. G-4199 and Gemcitabine, Hydrochloride Salt, Cat. No. G-4177.

 

dFdCyd — see Gemcitabine, Free Base, Cat. No. G-4199 and Gemcitabine, Hydrochloride Salt, Cat. No. G-4177.

D-9200

(R,S)-2,3-Dihydrodaidzein, >99%

 

4',7-Dihydroxyisoflavone — see Daidzein, Cat. No. D-2946.

 

4',7-Dihydroxyisoflavone, 7-O-β-D-glucopyranoside — see Daidzin, Cat. No. D-7878.

 

4',7-Dihydroxy-6-methoxyisoflavone — see Glycitein, Cat. No. G-1152.

 

17-(Dimethylaminoethylamino)-17-demethoxygeldanamycin — see 17-DMAG, Hydrochloride Salt, Cat. No. D-3440.

 

DJM-166 — see PX-866, Cat. No. P-7501.

 

DJM-2-166 — see PX-866, Cat. No. P-7501.

D-3440

17-DMAG, Hydrochloride Salt, >99%

D-1000

Docetaxel, >99%

D-2744

Doramapimod, Free Base, >99%

D-3608

Dovitinib, Free Base, >99%

D-3699

Dovitinib, Lactate Salt, >99%

 

Dox — see Doxorubicin, Free Base, Cat. No. D-4099 and Doxorubicin, Hydrochloride Salt, Cat. No. D-4000.

 

Doxil — see its active ingredient, namely Doxorubicin, Free Base, Cat. No. D-4099 and Doxorubicin, Hydrochloride Salt, Cat. No. D-4000.

D-4099

Doxorubicin, Free Base, >99%

D-4000

Doxorubicin, Hydrochloride Salt, >99%

 

dPAc — see Prostratin, Cat. No. P-4462.

 

DQ-2805 — see Irinotecan, Hydrochloride Salt, Trihydrate, Cat. No. I-4122.

 

Elactocin — see Leptomycin B, Free Acid, Cat. No. L-6100.

 

Elidel — see its active ingredient, namely Pimecrolimus, Cat. No. P-6040.

 

Ellence — see its active ingredient, namely Epirubicin, Hydrochloride Salt, Cat. No. E-8000.

 

Eloxatin — see its active ingredient, namely Oxaliplatin, Cat. No. O-7111.

 

Eloxatine — see Oxaliplatin, Cat. No. O-7111.

 

Elplat — see Oxaliplatin, Cat. No. O-7111.

E-3866

Entinostat, Free Base, >99%

E-4506

Enzastaurin, Free Base, >99%

 

Epiadriamycin — see its active ingredient, namely Epirubicin, Hydrochloride Salt, Cat. No. E-8000.

 

4'-Epidoxorubicin — see Epirubicin, Hydrochloride Salt, Cat. No. E-8000.

 

Epirubicin Ebewe — see its active ingredient, namely Epirubicin, Hydrochloride Salt, Cat. No. E-8000.

E-8000

Epirubicin, Hydrochloride Salt, >99%

 

EPO-906 — see Epothilone B, Free Base, Cat. No. E-5500.

 

EpoB — see Epothilone B, Free Base, Cat. No. E-5500.

 

Eposin — see its active ingredient, namely Etoposide, Cat. No. E-4488 and Etoposide 4'-Phosphate, Free Acid, Cat. No. E-4444.

E-5500

Epothilone B, Free Base, >99%

E-5880

(R,S)-Equol, >99%

 

Eril — see Fasudil, Monohydrochloride Salt, Cat. No. F-4660 and HA-1077, Dihydrochloride Salt, Cat. No. H-2330.

E-4997

Erlotinib, Free Base, >99%

E-4007

Erlotinib, Hydrochloride Salt, >99%

 

Etophos — see its active ingredient, namely Etoposide, Cat. No. E-4488 and Etoposide 4'-Phosphate, Free Acid, Cat. No. E-4444.

 

Etopofos — see its active ingredient, namely Etoposide, Cat. No. E-4488 and Etoposide 4'-Phosphate, Free Acid, Cat. No. E-4444.

 

Etopophos — see its active ingredient, namely Etoposide, Cat. No. E-4488 and Etoposide 4'-Phosphate, Free Acid, Cat. No. E-4444.

E-4488

Etoposide, >99%

 

Etoposide 4'-Dihydrogenphosphate — see Etoposide, Cat. No. E-4488 and Etoposide 4'-Phosphate, Free Acid, Cat. No. E-4444.

E-4444

Etoposide 4'-Phosphate, Free Acid, >99%

 

Eunades — see its active ingredient, namely Vinorelbine, Ditartrate Salt, Cat. No. V-8766 and Vinorelbine, Free Base, Cat. No. V-8799.

E-4040

Everolimus, >99%

 

Evotropin — see its active ingredient, namely Topotecan, Hydrochloride Salt, Cat. No. T-9622.

 

Exelbine — see its active ingredient, namely Vinorelbine, Ditartrate Salt, Cat. No. V-8766 and Vinorelbine, Free Base, Cat. No. V-8799.

 

Faridak — see Panobinostat, Free Base, Cat. No. P-3703.

 

Farmiblastina — see its active ingredient, namely Doxorubicin, Free Base, Cat. No. D-4099 and Doxorubicin, Hydrochloride Salt, Cat. No. D-4000.

 

Fasudil — see Fasudil, Monohydrochloride Salt, Cat. No. F-4660 and HA-1077, Dihydrochloride Salt, Cat. No. H-2330.

F-4660

Fasudil, Monohydrochloride Salt, >99%

 

FHPI — see SB 202190, Free Base, Cat. No. S-1700.

 

FI-106 — see Doxorubicin, Hydrochloride Salt, Cat. No. D-4000.

F-4633

Fingolimod, Hydrochloride Salt, >99%

F-4900

FK-506, >99%

 

FK-520 — see Ascomycin, Cat. No. A-1040.

 

Foloxatine — see Oxaliplatin, Cat. No. O-7111.

F-9929

Forskolin, >99%

 

FR 900520 — see Ascomycin, Cat. No. A-1040.

 

FTY720 — see Fingolimod, Hydrochloride Salt, Cat. No. F-4633.

 

FTY-720A — see Fingolimod, Hydrochloride Salt, Cat. No. F-4633.

 

Fujimycin — see FK-506, Cat. No. F-4900.

 

Gamcitabine — see its active ingredient, namely Gemcitabine, Free Base, Cat. No. G-4199 and Gemcitabine, Hydrochloride Salt, Cat. No. G-4177.

 

GDC-0449 — see Vismodegib, Free Base, Cat. No. V-4050.

G-9252

GDC-0941, Free Base, >99%

G-4408

Gefitinib, Free Base, >99%

G-4500

Geldanamycin, >99%

 

Geldanomycin — see Geldanamycin, Cat. No. G-4500.

G-4199

Gemcitabine, Free Base, >99%

G-4177

Gemcitabine, Hydrochloride Salt, >99%

 

Gemcitera — see its active ingredient, namely Gemcitabine, Free Base, Cat. No. G-4199 and Gemcitabine, Hydrochloride Salt, Cat. No. G-4177.

 

Gemsar — see its active ingredient, namely Gemcitabine, Free Base, Cat. No. G-4199 and Gemcitabine, Hydrochloride Salt, Cat. No. G-4177.

 

Gemzar — see its active ingredient, namely Gemcitabine, Free Base, Cat. No. G-4199 and Gemcitabine, Hydrochloride Salt, Cat. No. G-4177.

G-6055

Genistein, >99%

G-5200

Genistin, >99%

 

GLD-36 — see 17-AAG, Cat. No. A-6880.

 

Glamox — see its active ingredient, namely Imatinib, Free Base, Cat. No. I-5577 and Imatinib, Methanesulfonate Salt, Cat. No. I-5508.

 

Gleevec — see its active ingredient, namely Imatinib, Free Base, Cat. No. I-5577 and Imatinib, Methanesulfonate Salt, Cat. No. I-5508.

 

Glivec — see its active ingredient, namely Imatinib, Free Base, Cat. No. I-5577 and Imatinib, Methanesulfonate Salt, Cat. No. I-5508.

G-1152

Glycitein, >99%

G-2822

Glycitin, >99%

 

Goe 5549 — see CI-994, Free Base, Cat. No. C-2606.

 

Gö 5549 — see CI-994, Free Base, Cat. No. C-2606.

G-6203

Gö 6976, >99%

 

GSK-3 Inhibitor XVI — see CHIR99021, Free Base, Cat. No. C-6556.

 

GSK 572016 — see Lapatinib, Free Base, Cat. No. L-4899.

G-5903

GW2580, Free Base, >99%

 

GW-572016 — see Lapatinib, Free Base, Cat. No. L-4899 and Lapatinib, Di-p-Toluenesulfonate Salt, Cat. No. L-4804.

 

GW 572016X — see Lapatinib, Free Base, Cat. No. L-4899.

 

GW-786034 — see Pazopanib, Free Base, Cat. No. P-6706.

H-5239

H-89, Dihydrochloride Salt, >99%

 

HA-1077 — see Fasudil, Monohydrochloride Salt, Cat. No. F-4660 and HA-1077, Dihydrochloride Salt.

H-2330

HA-1077, Dihydrochloride Salt, >99%

 

Halochondrine A — see Okadaic Acid, Free Acid, Cat. No. O-2220.

 

Halochondrine A, Ammonium Salt — see Okadaic Acid, Ammonium Salt, Cat. No. O-6410.

 

Halochondrine A, Potassium Salt — see Okadaic Acid, Potassium Salt, Cat. No. O-7519.

 

Halochondrine A, Sodium Salt — see Okadaic Acid, Sodium Salt, Cat. No. O-5857.

 

HhAntag691 — see Vismodegib, Free Base, Cat. No. V-4050.

 

Histone Deacetylase Inhibitor I — see Entinostat, Free Base, Cat. No. E-3866.

 

HKI-272 — see Neratinib, Free Base, Cat. No. N-6404.

 

Hycamptamine — see its active ingredient, namely Topotecan, Hydrochloride Salt, Cat. No. T-9622.

 

Hycamtin — see its active ingredient, namely Topotecan, Hydrochloride Salt, Cat. No. T-9622.

 

14-Hydroxydaunomycin — see Doxorubicin, Free Base, Cat. No. D-4099 and Doxorubicin, Hydrochloride Salt, Cat. No. D-4000.

 

14-Hydroxydaunorubicine — see Doxorubicin, Free Base, Cat. No. D-4099 and Doxorubicin, Hydrochloride Salt, Cat. No. D-4000.

I-5577

Imatinib, Free Base, >99%

 

Imatinib Mesylate — see Imatinib, Methanesulfonate Salt, Cat. No. I-5508.

I-5508

Imatinib, Methanesulfonate Salt, >99%

 

Immunomycin — see Ascomycin, Cat. No. A-1040.

 

INCB018424 — see Ruxolitinib, Free Base, Cat. No. R-6600 and Ruxolitinib, Phosphate Salt, Cat. No. R-6688.

 

INCB18424 — see Ruxolitinib, Free Base, Cat. No. R-6600 and Ruxolitinib, Phosphate Salt, Cat. No. R-6688.

 

IND-71677 — see Iniparib, Cat. No. I-5432.

I-1711

(-)-Indolactam V, >99%

I-8560

Ingenol, >99%

I-5900

Ingenol 3-Angelate, >99%

 

3-Ingenyl Angelate — see Ingenol 3-Angelate, Cat. No. I-5900.

 

Ingenyl 3-Angelate — see Ingenol 3-Angelate, Cat. No. I-5900.

I-5432

Iniparib, 99%

I-9077

Intedanib, Free Base, >99%

 

4-Iodo-3-nitrobenzamide — see Iniparib, Cat. No. I-5432.

I-6800

Ionomycin, Calcium Salt, >99%

I-5700

Ionomycin, Free Acid, >99%

 

Iressa — see its active ingredient, namely Gefitinib, Free Base, Cat. No. G-4408.

I-4122

Irinotecan, Hydrochloride Salt, Trihydrate, >99%

 

4',7-Isoflavandiol — see Equol, Cat. No. E-5880.

 

Jakafi — see its active ingredient, namely Ruxolitinib, Free Base, Cat. No. D-4099 and Ruxolitinib, Phosphate Salt, Cat. No. D-4000.

 

JNK Inhibitor II — see SP600125, Cat. No. S-7979.

K-2151

K252a, >99%

K-9609

K252c, >99%

 

K-252a — see K252a, Cat. No. K-2151.

 

K-252c — see K252c, Cat. No. K-9609.

 

KOS-953 — see 17-AAG, Cat. No. A-6880.

 

KRN-951 — see Tivozanib, Free Base, Cat. No. T-6466.

 

KRX-0401 — see Perifosine, Cat. No. P-6522.

 

KT-5555 — see Lestaurtinib, Cat. No. L-6307.

K-9090

KU-0063794, Free Base, >99%

 

KU-59436 — see Olaparib, Cat. No. O-9201.

 

KU-63794 — see KU-0063794, Free Base, Cat. No. K-9090.

 

KW-2307 — see Vinorelbine, Ditartrate Salt, Cat. No. V-8766 and Vinorelbine, Free Base, Cat. No. V-8799.

 

KY 12420 — see Wortmannin, Cat. No. W-2990.

 

L 683590 — see Ascomycin, Cat. No. A-1040.

L-4804

Lapatinib, Di-p-Toluenesulfonate Salt, >99%

L-4899

Lapatinib, Free Base, >99%

 

Lastet — see its active ingredient, namely Etoposide, Cat. No. E-4488 and Etoposide 4'-Phosphate, Free Acid, Cat. No. E-4444.

 

LBH-589 — see Panobinostat, Free Base, Cat. No. P-3703.

 

LCP-Siro — see Rapamycin, Cat. No. R-5000.

L-6100

Leptomycin B, Free Acid, >99%

L-6307

Lestaurtinib, >99%

 

LG 1069 — see Bexarotene, Free Acid, Cat. No. B-2422.

 

LG100069 — see Bexarotene, Free Acid, Cat. No. B-2422.

 

LGD-1069 — see Bexarotene, Free Acid, Cat. No. B-2422.

 

Lipodox — see its active ingredient, namely Doxorubicin, Free Base, Cat. No. D-4099 and Doxorubicin, Hydrochloride Salt, Cat. No. D-4000.

 

LMB — see Leptomycin B, Free Acid, Cat. No. L-6100.

 

LY-188011 — see Gemcitabine, Free Base, Cat. No. G-4199 and Gemcitabine, Hydrochloride Salt, Cat. No. G-4177.

 

LY-231514 — see Pemetrexed, Disodium Salt, Heptahydrate, Cat. No. P-7177.

L-7962

LY 294002, >99%

 

LY-317615 — see Enzastaurin, Free Base, Cat. No. E-4506.

M-6730

6"-O-Malonyldaidzin, Free Acid, >98%

M-8090

6"-O-Malonylgenistin, Free Acid, >98%

M-4620

6"-O-Malonylglycitin, Free Acid, >98%

 

Mantuamycin — see Leptomycin B, Free Acid, Cat. No. L-6100.

 

Masatinib — see Masitinib, Free Base, Cat. No. M-7007.

M-7007

Masitinib, Free Base, >99%

 

ME-3167 — see (R,S)-Rolipram, Cat. No. R-2020.

 

MEK1/2 Inhibitor III — see PD 325901, Free Base, Cat. No. P-9688.

 

MG-0103 — see Mocetinostat, Free Base, Cat. No. M-2433.

 

MG-341 — see Bortezomib, Free Base, Cat. No. B-1408.

 

MGCD0103 — see Mocetinostat, Free Base, Cat. No. M-2433.

 

Midostaurin — see PKC412, Cat. No. P-7600.

 

MK-0683 — see Vorinostat, Cat. No. V-8477.

 

MK-8669 — see Ridaforolimus, Cat. No. R-7040.

 

MK-0457 — see Tozasertib, Free Base, Cat. No. T-2304.

 

MLN518 — see Tandutinib, Free Base, Cat. No. T-7802.

M-2433

Mocetinostat, Free Base, >99%

M-2999

Motesanib, Diphosphate Salt, >99%

M-2900

Motesanib, Free Base, 99%

 

MS-27-275 — see Entinostat, Free Base, Cat. No. E-3866.

 

MS-275 — see Entinostat, Free Base, Cat. No. E-3866.

 

MS 275-27 — see Entinostat, Free Base, Cat. No. E-3866.

 

MTA — see Pemetrexed, Disodium Salt, Heptahydrate, Cat. No. P-7177.

M-5602

Mubritinib, Free Base, >99%

 

Myocet — see its active ingredient, namely Doxorubicin, Free Base, Cat. No. D-4099 and Doxorubicin, Hydrochloride Salt, Cat. No. D-4000.

 

Navelbine — see its active ingredient, namely Vinorelbine, Ditartrate Salt, Cat. No. V-8766 and Vinorelbine, Free Base, Cat. No. V-8799.

 

NCB018424 — see Ruxolitinib, Free Base, Cat. No. R-6600 and Ruxolitinib, Phosphate Salt, Cat. No. R-6688.

 

NCB18424 — see Ruxolitinib, Free Base, Cat. No. R-6600 and Ruxolitinib, Phosphate Salt, Cat. No. R-6688.

 

Nectrolide — see Brefeldin A, Cat. No. B-8500.

N-6404

Neratinib, Free Base, >99%

 

Nexavar — see its active ingredient, namely Sorafenib, p-Toluenesulfonate Salt, Cat. No. S-8502 and Sorafenib, Free Base, Cat. No. S-8599.

N-8207

Nilotinib, Free Base, >99%

 

Nintedanib — see Intedanib, Free Base, Cat. No. I-9077.

 

NKA17 — see Perifosine, Cat. No. P-6522.

 

Nogitecan — see its active ingredient, namely Topotecan, Hydrochloride Salt, Cat. No. T-9622 .

 

5'-Noranhydrovinblastine — see Vinorelbine, Ditartrate Salt, Cat. No. V-8766 and Vinorelbine, Free Base, Cat. No. V-8799.

 

Novaplus — see its active ingredient, namely Etoposide, Cat. No. E-4488 and Etoposide 4'-Phosphate, Free Acid, Cat. No. E-4444.

 

NVB — see Vinorelbine, Ditartrate Salt, Cat. No. V-8766 and Vinorelbine, Free Base, Cat. No. V-8799.

N-5300

NVP-AUY922, Free Base, >99%

N-4288

NVP-BEZ235, Free Base, >99%

 

NVP-LBH-589 — see Panobinostat, Free Base, Cat. No. P-3703.

O-1666

ODQ, Free Base, >98%

O-6410

Okadaic Acid, Ammonium Salt, >98%

O-2220

Okadaic Acid, Free Acid, >98%

O-7519

Okadaic Acid, Potassium Salt, >98%

O-5857

Okadaic Acid, Sodium Salt, >98%

O-9201

Olaparib, >99%

 

Onsenal — see Celecoxib, Cat. No. C-1502.

 

OSI-774 — see Erlotinib, Free Base, Cat. No. E-4997 and Erlotinib, Hydrochloride Salt, Cat. No. E-4007.

O-5679

OSU-03012, Hydrochloride Salt, >99%

 

OSU03012 — see OSU-03012, Hydrochloride Salt, Cat. No. O-5679.

 

1H-[1,2,4]oxadiazolo[4,3-a]quinoxalin-1-one — see ODQ, Free Base, Cat. No. O-1666.

 

Oxalato(1R,2R-cyclohexanediamine)platinum(II) — see Oxaliplatin, Cat. No. O-7111.

 

Oxalatoplatin — see Oxaliplatin, Cat. No. O-7111.

 

Oxalatoplatinum — see Oxaliplatin, Cat. No. O-7111.

O-7111

Oxaliplatin, >99%

P-9600

Paclitaxel, >99.5%

P-3703

Panobinostat, Free Base, >99%

 

Patupilone — see Epothilone B, Free Base, Cat. No. E-5500.

P-6706

Pazopanib, Free Base, >99%

P-4313

PD 98059, >99%

 

PD 114720 — see Leptomycin B, Free Acid, Cat. No. L-6100.

 

PD 123654 — see CI-994, Free Base, Cat. No. C-2606.

P-3333

PD 173074, Free Base, >99%

 

PD 183805 — see Canertinib, Dihydrochloride Salt, Cat. No. C-1201.

P-8499

PD 184352, Free Base, >99%

P-9688

PD 325901, Free Base, >99%

 

PD0325901 — see PD 325901, Free Base, Cat. No. P-9688.

 

PD 406976 — see Gö 6976, Cat. No. G-6203.

 

PDBu — see Phorbol 12,13-Dibutyrate, Cat. No. P-4833.

 

4α-PDD — see 4α-Phorbol 12,13-Didecanoate, Cat. No. P-2170.

P-7177

Pemetrexed, Disodium Salt, Heptahydrate, >99%

 

PEP005 — see Ingenol 3-Angelate, Cat. No. I-5900.

P-6522

Perifosine, >99%

 

PF-02341066 — see Crizotinib, Free Base, Cat. No. C-7900.

 

PF-1066 — see Crizotinib, Free Base, Cat. No. C-7900.

 

PF-02341066 — see Crizotinib, Free Base, Cat. No. C-7900.

 

PHA-290940AD — see Sunitinib, Malate Salt, Cat. No. S-8803 and Sunitinib, Free Base, Cat. No. S-8877.

 

Pharmorubicin — see its active ingredient, namely Epirubicin, Hydrochloride Salt, Cat. No. E-8000.

P-1010

Phorbol, >99%

P-4833

Phorbol 12,13-Dibutyrate, >99%

P-2170

4α-Phorbol 12,13-Didecanoate, >99%

P-1680

Phorbol 12-Myristate 13-Acetate, >99.5%

P-8880

4α-Phorbol 12-Myristate 13-Acetate, >99%

 

PI3-Kinase α Inhibitor VIII — see PIK-75, Free Base, Cat. No. P-7858 and PIK-75, Hydrochloride Salt, Cat. No. P-7050.

P-7858

PIK-75, Free Base, >98%

P-7050

PIK-75, Hydrochloride Salt, >98%

P-9050

PIK-90, Free Base, >98%

P-6040

Pimecrolimus, >99%

P-7600

PKC412, >99%

 

PLX4032 — see Vemurafenib, Free Base, Cat. No. V-2800.

 

PMA — see Phorbol 12-Myristate 13-Acetate, Cat. No. P-1680.

 

4α-PMA — see 4α-Phorbol 12-Myristate 13-Acetate, Cat. No. P-8880.

 

PNU-290940AD — see Sunitinib, Malate Salt, Cat. No. S-8803 and Sunitinib, Free Base, Cat. No. S-8877.

P-6666

PP242, Free Base, >99%

 

Prograf — see FK-506, Cat. No. F-4900.

P-4462

Prostratin, >99%

 

PS-341 — see Bortezomib, Free Base, Cat. No. B-1408.

 

PTK 787 — see Vatalanib, Dihydrochloride Salt, Cat. No. V-8303 and Vatalanib, Free Base, Cat. No. V-8355.

 

PTK/ZK — see Vatalanib, Dihydrochloride Salt, Cat. No. V-8303 and Vatalanib, Free Base, Cat. No. V-8355.

P-7501

PX-866, >99%

 

Pynasunate — see Vatalanib, Dihydrochloride Salt, Cat. No. V-8303 and Vatalanib, Free Base, Cat. No. V-8355.

 

1,9-Pyrazoloanthrone — see SP600125, Cat. No. S-7979.

Q-4747

Quizartinib, Free Base, >99%

 

R-115777 — see Tipifarnib, Free Base, Cat. No. T-9104.

 

R7204 — see Vemurafenib, Free Base, Cat. No. V-2800.

 

RAD001 — see Everolimus, Cat. No. E-4040.

 

Ramihyphin A — see Cyclosporin A, Cat. No. C-6000.

 

RAPA — see Rapamycin, Cat. No. R-5000.

 

Rapamune — see Rapamycin, Cat. No. R-5000.

R-5000

Rapamycin, >99%

 

Recentin — see its active ingredient, namely Cediranib, Free Base, Cat. No. C-4300.

R-6712

Resiniferatoxin, >99%

R-8765

Resiniferonol 9,13,14-Orthophenylacetate, >99%

 

RG7204 — see Vemurafenib, Free Base, Cat. No. V-2800.

R-7040

Ridaforolimus, >99%

 

Ridorubicin — see its active ingredient, namely Epirubicin, Hydrochloride Salt, Cat. No. E-8000.

 

ROPA — see Resiniferonol 9,13,14-Orthophenylacetate, Cat. No. R-8765.

 

Ro 09-1978 — see Capecitabine, Cat. No. C-2799.

 

Ro 50-8231 — see Erlotinib, Free Base, Cat. No. E-4997 and Erlotinib, Hydrochloride Salt, Cat. No. E-4007.

 

RO5185426 — see Vemurafenib, Free Base, Cat. No. V-2800.

 

Rolazar — see Pemetrexed, Disodium Salt, Heptahydrate, Cat. No. P-7177.

R-2020

(R,S)-Rolipram, >99%

R-1234

Roscovitine, Free Base, >99%

R-9630

Rottlerin

 

RP 54780— see Oxaliplatin, Cat. No. O-7111.

 

RP 56976— see Docetaxel, Cat. No. D-1000.

 

RTX — see Resiniferatoxin, Cat. No. R-6712.

 

Rubex — see its active ingredient, namely Doxorubicin, Free Base, Cat. No. D-4099 and Doxorubicin, Hydrochloride Salt, Cat. No. D-4000.

R-6600

Ruxolitinib, Free Base

R-6688

Ruxolitinib, Phosphate Salt

 

SAHA — see Vorinostat, Cat. No. V-8477.

 

SAPK Inhibitor II — see SP600125, Cat. No. S-7979.

S-8906

Saracatinib, Free Base, >99%

S-1700

SB 202190, Free Base, >99%

S-3400

SB 203580, Free Base, >99%

S-5100

SB 225002, >99%

 

SB 95952 — see (R,S)-Rolipram, Cat. No. R-2020.

 

SC-58635 — see Celecoxib, Cat. No. C-1502.

 

SDP-012 — see Vinorelbine, Ditartrate Salt, Cat. No. V-8766 and Vinorelbine, Free Base, Cat. No. V-8799.

 

SDZ-ASM-981 — see Pimecrolimus, Cat. No. P-6040.

 

SDZ-RAD — see Everolimus, Cat. No. E-4040.

 

Seliciclib — see Roscovitine, Free Base, Cat. No. R-1234.

S-4490

Selumetinib, Free Base, >99%

S-7272

Sepantronium Bromide, 98%

 

SILA 9268A — see Rapamycin, Cat. No. R-5000.

 

Sirolimus — see Rapamycin, Cat. No. R-5000.

 

SKF-104864A — see Topotecan, Hydrochloride Salt, Cat. No. T-9622.

 

SKI-606 — see Bosutinib, Free Base, Cat. No. B-1709.

 

SNDX-275 — see Entinostat, Free Base, Cat. No. E-3866.

 

Solexa — see Celecoxib, Cat. No. C-1502.

S-8599

Sorafenib, Free Base, >99%

S-8502

Sorafenib, p-Toluenesulfonate Salt, >99%

 

Sorafenib Tosylate — see Sorafenib, p-Toluenesulfonate Salt, Cat. No. S-8502.

S-7979

SP600125, >99%

 

Sprycel — see its active ingredient, namely Dasatinib, Free Base, Cat. No. D-3307.

 

SR1 — see StemRegenin 1, Free Base, Cat. No. S-2440.

 

SR-11247 — see Bexarotene, Free Acid, Cat. No. B-2422.

S-9344

Stauprimide, >99%

S-9300

Staurosporine, Free Base, >99%

 

Staurosporine Aglycone — see K-252c, Cat. No. K-9609.

 

Staurosporinone — see K-252c, Cat. No. K-9609.

S-2440

StemRegenin 1, Free Base, >99%

 

STI-571 — see Imatinib, Free Base, Cat. No. I-5577 and Imatinib, Methanesulfonate Salt, Cat. No. I-5508.

 

SU-11248 — see Sunitinib, Malate Salt, Cat. No. S-8803 and Sunitinib, Free Base, Cat. No. S-8877.

 

Suberanilohydroxamic Acid — see Vorinostat, Cat. No. V-8477.

 

Suberoylanilide Hydroxamic Acid — see Vorinostat, Cat. No. V-8477.

S-8877

Sunitinib, Free Base, >99%

 

Sunitinib Maleate — see Sunitinib, Malate Salt, Cat. No. S-8803.

S-8803

Sunitinib, Malate Salt, >99%

 

Sutent — see its active ingredient, namely Sunitinib, Malate Salt, Cat. No. S-8803 and Sunitinib, Free Base, Cat. No. S-8877.

 

Synergisidin — see Brefeldin A, Cat. No. B-8500.

 

Tacedinaline — see CI-994, Free Base, Cat. No. C-2606.

 

Tacrolimus — see FK-506, Cat. No. F-4900.

 

TAK-165 — see Mubritinib, Free Base, Cat. No. M-5602.

T-7802

Tandutinib, Free Base, >99%

 

Tanespimycin — see 17-AAG, Cat. No. A-6880.

 

Tarceva — see its active ingredient, namely Erlotinib, Free Base, Cat. No. E-4997 and Erlotinib, Hydrochloride Salt, Cat. No. E-4007.

 

Targretin — see its active ingredient, namely Bexarotene, Free Acid, Cat. No. B-2422.

 

Targretyn — see Bexarotene, Free Acid, Cat. No. B-2422.

 

Targrexin — see Bexarotene, Free Acid, Cat. No. B-2422.

 

Tasigna — see its active ingredient, namely Nilotinib, Free Base, Cat. No. N-8207.

 

Tasocitinib — see Tofacitinib, Free Base, Cat. No. T-1377.

 

Taxol — see Paclitaxel, Cat. No. P-9600.

 

Taxotere — see Docetaxel, Cat. No. D-1000.

 

Telatinib — see 17-AAG, Cat. No. A-6880.

T-8040

Temsirolimus, >99%

 

12-O-Tetradecanoylphorbol 13-Acetate — see Phorbol 12-Myristate 13-Acetate, Cat. No. P-1680.

 

4α-12-O-Tetradecanoylphorbol 13-Acetate — see 4α-Phorbol 12-Myristate 13-Acetate, Cat. No. P-8880.

T-3250

Thapsigargin, >99%

 

Tifolar — see Pemetrexed, Disodium Salt, Heptahydrate, Cat. No. P-7177.

T-5096

Tinyatoxin, >99%

T-9104

Tipifarnib, Free Base, >99%

T-6466

Tivozanib, Free Base, 99%

 

TKI-258 — see Dovitinib, Free Base, Cat. No. D-3608 and Dovitinib, Lactate Salt, Cat. No. D-3699.

 

TNX — see Tinyatoxin, Cat. No. T-5096.

T-1377

Tofacitinib, Free Base, >99%

 

Tomtovok — see its active ingredient, namely Afatinib, Free Base, Cat. No. A-8644.

 

Toposar — see its active ingredient, namely Etoposide, Cat. No. E-4488 and Etoposide 4'-Phosphate, Free Acid, Cat. No. E-4444.

T-9622

Topotecan, Hydrochloride Salt, >99%

 

Topotecin — see Irinotecan, Hydrochloride Salt, Trihydrate, Cat. No. I-4122.

 

Torisel — see its active ingredient, namely Temsirolimus, Cat. No. T-8040.

 

Torkinib — see PP242, Free Base, Cat. No. P-6666.

 

Tovok — see its active ingredient, namely Afatinib, Free Base, Cat. No. A-8644.

T-2304

Tozasertib, Free Base, 99%

 

TPA — see Phorbol 12-Myristate 13-Acetate, Cat. No. P-1680.

 

4α-TPA — see 4α-Phorbol 12-Myristate 13-Acetate, Cat. No. P-8880.

 

Transplatin — see Oxaliplatin, Cat. No. O-7111.

 

4',5,7-Trihydroxyisoflavone — see Genistein, Cat. No. G-6055.

 

Tykerb — see its active ingredient, namely Lapatinib, Free Base, Cat. No. L-4899 and Lapatinib, Di-p-Toluenesulfonate Salt, Cat. No. L-4804.

T-9142

Tyrphostin AG 490, >99%

T-7310

Tyrphostin AG 1478, Free Base, >99%

 

Tyrphostin B42 — see Tyrphostin AG 490, Cat. No. T-9142.

 

Tyverb — see its active ingredient, namely Lapatinib, Free Base, Cat. No. L-4899 and Lapatinib, Di-p-Toluenesulfonate Salt, Cat. No. L-4804.

 

TYX — see Tinyatoxin, Cat. No. T-5096.

U-6770

U0126, >99%

 

U-29135 — see Geldanamycin, Cat. No. G-4500.

 

U-101440E — see Irinotecan, Hydrochloride Salt, Trihydrate, Cat. No. I-4122.

V-9402

Vandetanib, Free Base, >99%

 

Vargatef — see its active ingredient, namely Intedanib, Free Base, Cat. No. I-9077.

V-8303

Vatalanib, Dihydrochloride Salt, >99%

V-8355

Vatalanib, Free Base, >99%

 

Velcade — see Bortezomib, Free Base, Cat. No. B-1408.

V-2800

Vemurafenib, Free Base, >99%

 

Vepesid — see its active ingredient, namely Etoposide, Cat. No. E-4488 and Etoposide 4'-Phosphate, Free Acid, Cat. No. E-4444.

 

VER-52296 — see NVP-AUY922, Free Base, Cat. No. N-5300.

V-8766

Vinorelbine, Ditartrate Salt, >99%

V-8799

Vinorelbine, Free Base, >98%

V-4050

Vismodegib, Free Base, >99%

V-8477

Vorinostat, >99%

 

VP-16 — see Etoposide, Cat. No. E-4488 and Etoposide 4'-Phosphate, Free Acid, Cat. No. E-4444.

 

VP-16-213 — see Etoposide, Cat. No. E-4488 and Etoposide 4'-Phosphate, Free Acid, Cat. No. E-4444.

 

VX6 — see Tozasertib, Free Base, Cat. No. T-2304.

 

VX-680 — see Tozasertib, Free Base, Cat. No. T-2304.

V-9366

VX-702, Free Base, >99%

W-2990

Wortmannin, >99%

 

Xabine — see Capecitabine, Cat. No. C-2799.

 

Xalkori — see its active ingredient, namely Crizotinib, Free Base, Cat. No. C-7900.

 

Xeloda — see its active ingredient, namely Capecitabine, Cat. No. C-2799.

 

YM155 — see Sepantronium Bromide, Cat. No. S-7272.

 

YM-177 — see Celecoxib, Cat. No. C-1502.

 

Zactima — see Vandetanib, Free Base, Cat. No. V-9402.

 

Zarnestra — see its active ingredient, namely Tipifarnib, Free Base, Cat. No. T-9104.

 

ZD-1839 — see Gefitinib, Free Base, Cat. No. G-4408.

 

ZD6474 — see Vandetanib, Free Base, Cat. No. V-9402.

 

Zelboraf — see its active ingredient, namely Vemurafenib, Free Base, Cat. No. V-2800.

 

ZK222584 — see Vatalanib, Dihydrochloride Salt, Cat. No. V-8303 and Vatalanib, Free Base, Cat. No. V-8355.

 

ZK-62711 — see (R,S)-Rolipram, Cat. No. R-2020.

 

Zolinza — see its active ingredient, namely Vorinostat, Cat. No. V-8477.

 

Zortress — see its active ingredient, namely Everolimus, Cat. No. E-4040.

Z-9040

Zotarolimus, >98%

 

Zuyeyidal — see its active ingredient, namely Etoposide, Cat. No. E-4488 and Etoposide 4'-Phosphate, Free Acid, Cat. No. E-4444.

Z-1066

ZSTK474, Free Base, >99%